Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,345.00up ₹9.60 (0.72%)BSE ₹1,338.50
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,335.40.
29 Oct: open ₹1,343.50, high ₹1,352.80, low ₹1,336.10
52-week range of traded prices to 29 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,264 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.10
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 20,20,77261.4% delivered
Dr. Reddy's Laboratories shareholding disclosures
153 filed, newest first. Page 4 of 4.
Feb 2009
16 Feb · Disclosure
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that "We have been informed by the promoters/promoter group of the company that pledge on 4,10,000 equity shares of the company held by them, have been released. Accordingly, the percentage of pledged shares has come down from 6.19% to 5.94% of the outstanding share capital of the company as on Febuary 16, 2009." The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).6 Feb · Disclosure
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has been informed by the promoters / promoter group of the Company that they have pledged 10,419,829 equity shares of the Company held by them. This represents 6.19% of the company's outstanding shares as on date. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
18 Dec · Disclosure
Dr. Reddy's Laboratories Ltd. has informed the Exchange that "Pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 7,000 ADRs of Rs.5 each of the Company on December 17, 2008, to US Employee of the Company who has exercised his ADR Stock Options."